Cadre Holdings, Inc. (NYSE:CDRE – Get Free Report) Director Nicolas Sokolow sold 1,095 shares of the business’s stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $34.10, for a total value of $37,339.50. Following the completion of the transaction, the director now directly owns 83,208 shares of the company’s stock, valued at approximately $2,837,392.80. This trade represents a 1.30 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.
Nicolas Sokolow also recently made the following trade(s):
- On Friday, November 22nd, Nicolas Sokolow sold 5,000 shares of Cadre stock. The shares were sold at an average price of $33.25, for a total value of $166,250.00.
Cadre Price Performance
CDRE stock opened at $33.45 on Friday. Cadre Holdings, Inc. has a 1 year low of $29.18 and a 1 year high of $40.28. The firm has a market capitalization of $1.36 billion, a PE ratio of 40.30, a price-to-earnings-growth ratio of 1.98 and a beta of 1.30. The business has a 50 day simple moving average of $36.37 and a 200-day simple moving average of $34.95. The company has a debt-to-equity ratio of 0.65, a current ratio of 3.01 and a quick ratio of 1.96.
Cadre Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, November 1st were paid a dividend of $0.0875 per share. This represents a $0.35 dividend on an annualized basis and a yield of 1.05%. The ex-dividend date was Friday, November 1st. Cadre’s dividend payout ratio (DPR) is 42.17%.
Institutional Inflows and Outflows
A number of large investors have recently added to or reduced their stakes in the company. Franklin Resources Inc. purchased a new stake in shares of Cadre during the third quarter worth $208,000. Geode Capital Management LLC grew its holdings in shares of Cadre by 15.1% during the third quarter. Geode Capital Management LLC now owns 583,678 shares of the company’s stock worth $22,155,000 after purchasing an additional 76,750 shares during the last quarter. Barclays PLC grew its holdings in shares of Cadre by 335.6% during the third quarter. Barclays PLC now owns 53,397 shares of the company’s stock worth $2,025,000 after purchasing an additional 41,139 shares during the last quarter. Jane Street Group LLC grew its holdings in shares of Cadre by 16.8% during the third quarter. Jane Street Group LLC now owns 34,144 shares of the company’s stock worth $1,296,000 after purchasing an additional 4,918 shares during the last quarter. Finally, Fred Alger Management LLC boosted its stake in shares of Cadre by 87.5% during the third quarter. Fred Alger Management LLC now owns 738,121 shares of the company’s stock worth $28,012,000 after buying an additional 344,483 shares during the period. 43.95% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
Separately, Roth Mkm cut their price target on Cadre from $39.00 to $37.00 and set a “buy” rating for the company in a research note on Thursday, November 7th. Two equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $39.75.
View Our Latest Analysis on CDRE
Cadre Company Profile
Cadre Holdings, Inc manufactures and distributes safety that provides protection to users in hazardous or life-threatening situations in the United States and internationally. The company operates in two segments, Products and Distribution. It offers body armor product, such as concealable, corrections, and tactical armor under the Safariland and Protech Tactical brand names; survival suits, remotely operated vehicles, specialty tools, blast sensors, accessories, and vehicle blast attenuation seats for bomb safety technicians; bomb suits; duty gear, including belts and accessories; and other protective equipment comprising communications gear, forensic and investigation products, firearms cleaning solutions, and crowd control products.
See Also
- Five stocks we like better than Cadre
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- How to Calculate Stock Profit
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- What is the Euro STOXX 50 Index?
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for Cadre Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cadre and related companies with MarketBeat.com's FREE daily email newsletter.